1. Home >
  2. Companies >
  3. Public >
  4. Life Science >
  5. United States >
  6. New Jersey >
  7. Celldex Therapeutics >
  8. M&A

Celldex Therapeutics Mergers & Acquisitions

Celldex Therapeutics M&A Summary

Celldex Therapeutics has acquired 3 companies.

Celldex Therapeutics’ largest acquisition to date was in 2009, when it acquired CuraGen for $95M. Celldex Therapeutics has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 1
  • Total Countries Invested 1

Celldex Therapeutics

Celldex Therapeutics, Inc.

Perryville III Building, Suite 220 53 Frontage Road,
Hampton, New Jersey 08827
United States,
(908) 200-7500
www.celldex.com

All (3) Buy (3) Sell (-)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2016-11-01 Kolltan Pharmaceuticals, Inc. · Life Science
New Haven, Connecticut · www.kolltan.com

Kolltan Pharmaceuticals, Inc. is a privately held biopharmaceutical company focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs).

Advisors: Guggenheim Securities , Holland & Knight 		63 Add-on Acquisition

Celldex Therapeutics
Advisor: Lowenstein Sandler

-

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal